Nursing and Pharmacy Perspectives: Strategies for Optimizing the Care of Patients With Metastatic Melanoma

Are you up to date on treating patients with advanced melanoma with the latest checkpoint inhibitor combination lymphocyte activating gene 3 (LAG3)/programmed cell death protein 1 (PD-1)?

Credit available for this activity expires: 5/30/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/992505?ecd=bdc_podcast_libsyn_mscpedu